These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 19099197)
1. Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas. Nojiri T; Nariai T; Aoyagi M; Senda M; Ishii K; Ishiwata K; Ohno K J Neurooncol; 2009 Jun; 93(2):233-41. PubMed ID: 19099197 [TBL] [Abstract][Full Text] [Related]
2. Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Kracht LW; Friese M; Herholz K; Schroeder R; Bauer B; Jacobs A; Heiss WD Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):868-73. PubMed ID: 12692687 [TBL] [Abstract][Full Text] [Related]
3. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography. Shinozaki N; Uchino Y; Yoshikawa K; Matsutani T; Hasegawa A; Saeki N; Iwadate Y J Neurosurg; 2011 Jun; 114(6):1640-7. PubMed ID: 21214332 [TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344 [TBL] [Abstract][Full Text] [Related]
5. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine. Derlon JM; Petit-Taboué MC; Chapon F; Beaudouin V; Noël MH; Creveuil C; Courtheoux P; Houtteville JP Neurosurgery; 1997 Feb; 40(2):276-87; discussion 287-8. PubMed ID: 9007859 [TBL] [Abstract][Full Text] [Related]
6. Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation. Roessler K; Gatterbauer B; Becherer A; Paul M; Kletter K; Prayer D; Hoeftberger R; Hainfellner J; Asenbaum S; Knosp E Minim Invasive Neurosurg; 2007 Oct; 50(5):273-80. PubMed ID: 18058643 [TBL] [Abstract][Full Text] [Related]
7. Microvessel density in brain tumors. Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601 [TBL] [Abstract][Full Text] [Related]
8. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. Ceyssens S; Van Laere K; de Groot T; Goffin J; Bormans G; Mortelmans L AJNR Am J Neuroradiol; 2006 Aug; 27(7):1432-7. PubMed ID: 16908552 [TBL] [Abstract][Full Text] [Related]
9. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling. Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240 [TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. Ribom D; Eriksson A; Hartman M; Engler H; Nilsson A; Långström B; Bolander H; Bergström M; Smits A Cancer; 2001 Sep; 92(6):1541-9. PubMed ID: 11745233 [TBL] [Abstract][Full Text] [Related]
12. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using f-18-fluorodeoxyglucose and c-11-L-methylmethionine. Hölzer T Neurosurgery; 1998 May; 42(5):1200-1. PubMed ID: 9588575 [No Abstract] [Full Text] [Related]
13. Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors. Ericson K; Lilja A; Bergström M; Collins VP; Eriksson L; Ehrin E; von Holst H; Lundqvist H; Långsrom B B; Mosskin M J Comput Assist Tomogr; 1985; 9(4):683-9. PubMed ID: 3926834 [TBL] [Abstract][Full Text] [Related]
15. Relatively decreased 11C-methionine uptake within the anaplastic component of a mixed-grade oligodendroglioma. Miwa K; Shinoda J; Yano H; Iwama T AJNR Am J Neuroradiol; 2007; 28(10):2005-7. PubMed ID: 17905896 [TBL] [Abstract][Full Text] [Related]
16. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours. Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the accumulation kinetics of L-(methyl-11C)-methionine and D-(methyl-11C)-methionine in brain tumors studied with positron emission tomography. Bergström M; Lundqvist H; Ericson K; Lilja A; Johnström P; Långström B; von Holst H; Eriksson L; Blomqvist G Acta Radiol; 1987; 28(3):225-9. PubMed ID: 2958026 [TBL] [Abstract][Full Text] [Related]
19. Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach. Latysheva A; Emblem KE; Brandal P; Vik-Mo EO; Pahnke J; Røysland K; Hald JK; Server A Neuroradiology; 2019 May; 61(5):545-555. PubMed ID: 30712139 [TBL] [Abstract][Full Text] [Related]
20. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours. Sasaki M; Kuwabara Y; Yoshida T; Nakagawa M; Fukumura T; Mihara F; Morioka T; Fukui M; Masuda K Eur J Nucl Med; 1998 Sep; 25(9):1261-9. PubMed ID: 9724375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]